EV-077 in vitro inhibits platelet aggregation in type-2 diabetics on aspirin
Kjell S. Sakaríassen(Ospedale degli Infermi), Rodolfo Pedro Rothlin(Universidad de Buenos Aires), Arnaldo Armesto(Universidad de Buenos Aires), Gian Marco Podda(University of Milan), Mariateresa Pugliano(University of Milan), Federico M. Daray(Universidad de Buenos Aires), Eti Alessandra Femia(University of Milan), Andrea Emilse Errasti(Consejo Nacional de Investigaciones Científicas y Técnicas), Marco Cattaneo(University of Milan), Cristina Razzari(University of Milan), Jean‐Philippe Meyer(Evolva (Switzerland)), Alexandra Santana Sorensen(Evolva (Switzerland)), Pēteris Alberts(Maxygen (United States))
Cited by 17
Related Papers
Aspirin resistance: position paper of the Working Group on Aspirin Resistance
|Journal of Thrombosis and Haemostasis|2005|329
Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Improves Hepatic Insulin Sensitivity in Hyperglycemic Mice Strains
|Endocrinology|2003|263
Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice
|Diabetologia|2002|259
Combined Effect of Factor V Leiden and Prothrombin 20210A on the Risk of Venous Thromboembolism
|Thrombosis and Haemostasis|2001|235